Katri Lindfors

Activities

Activities per year 2003 2009 2010 2011 2012 2013 2019 2022

• 172 Conference presentation
• 29 Reviewer of Scientific Journal
• 14 Supervisor of master student
• 7 Supervisor of doctoral candidate
• 41 More
  • 7 Invited lecture
  • 6 Pre-examination of dissertation or acting as opponent to doctoral students
  • 5 Regular membership of a society or network
  • 5 Position of trust in a funding organization
  • 4 Media appearance
  • 3 Supervisor of licentiate candidate in medicine
  • 2 Chair of workshop, panel, session or tutorial
  • 2 Membership of an organizing committee of a conference or seminar
  • 2 Public talk
  • 1 Membership of a scientific or program committee of a conference or seminar
  • 1 Consultancy
  • 1 Position of trust in a society or network
  • 1 Academic qualification (e.g. title of docent)
  • 1 Leadership of a scientific program or project

Activities per year

Search results

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  22 Nov 2011

  Activity: Talk or presentation › Conference presentation

• Are transglutaminase 2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease? A proof-of-concept study

  Tiina Rauhavirta (Speaker), Katri Kaukinen (Speaker), Katri Lindfors (Speaker) & Markku Mäki (Speaker)

  22 Nov 2011

  Activity: Talk or presentation › Conference presentation

• Features of early developing coeliac diasease can be induced in mice by passive transfer of patient serum

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  22 Nov 2011

  Activity: Talk or presentation › Conference presentation

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease?

  Tiina Rauhavirta (Contributor), Rami Kivistö (Contributor), Ilma Korponay-Szabó (Contributor), Pekka T Männistö (Contributor), J. Arturo Garcia-Horsman (Contributor), Mongeot Alexandre (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  22 Jun 2011

  Activity: Talk or presentation › Conference presentation

• Superior performance of transglutaminase 2 antibody assay against open conformation of the enzyme in celiac disease

  Katri Lindfors (Speaker), Outi Koskinen (Speaker), Kalle Kurppa (Speaker), Kaija Laurila (Speaker), Pekka Collin (Speaker), Katri Haimila (Speaker), Jukka Partanen (Speaker), Päivi Saavalainen (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  20 Jun 2011

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  20 Jun 2011

  Activity: Talk or presentation › Conference presentation

• Serum markers suitable for the study ond early recognition of celiac disease

  Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Alina Popp (Contributor) & Mauno Vihinen (Contributor)

  13 Jun 2011

  Activity: Talk or presentation › Conference presentation

• Celiac Patient Transglutaminase 2-Targeted Autoantibodies Inhibit in Vivo Angiogenesis Likely Through Overexpression of RhoB

  Katri Lindfors (Speaker), Sergio Caja (Speaker), Stefanie Martucciello (Speaker), Miha Lavric (Speaker), Ilma Korponay-Szabo (Speaker), Cristina Nadalutti (Speaker), Tiina Rauhavirta (Speaker), Carla Esposito (Speaker), Ana-Marija Sulic (Speaker), Daniele Sblattero (Speaker), Roberto Marzari (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  28 May 2011

  Activity: Talk or presentation › Conference presentation

• Celiac patient transglutaminase 2-targeted autoantibodies inhibit in vivo angiogenesis likely through overexpression of RhoB

  Katri Lindfors (Contributor), Sergio Caja (Contributor), Stefanie Martucciello (Contributor), Miha Lavric (Contributor), Ilma Korponay-Szabo (Contributor), Cristina Nadalutti (Contributor), Tiina Rauhavirta (Contributor), Carla Esposito (Contributor), Ana-Marija Sulic (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Markku Mäki (Contributor) & Katri Kaukinen (Contributor)

  28 May 2011

  Activity: Talk or presentation › Conference presentation

• Treatment of screen-Detected and asymptomatic coeliac disease patients. A randomized clinical trial

  Kalle Kurppa (Contributor), Pekka Collin (Contributor), Heini Huhtala (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  26 May 2011

  Activity: Talk or presentation › Conference presentation

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to celiac disease? A proof-of-concept study

  Katri Lindfors (Speaker), Tiina Rauhavirta (Speaker), Rami Kivistö (Speaker), Pekka Männistö (Speaker), Arturo Garcia-Horsman (Speaker), Martin Griffin (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  26 May 2011

  Activity: Talk or presentation › Conference presentation

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to celiac disease – a proof-of-concept study

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor) & Tiina Rauhavirta (Contributor)

  9 May 2011

  Activity: Talk or presentation › Conference presentation

• Overexpression of RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

  Katri Lindfors (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor) & Tiina Rauhavirta (Contributor)

  9 May 2011

  Activity: Talk or presentation › Conference presentation

• Should screen-detected and asymptomatic celiac disease patients be treated? A prospective and randomized trial

  Kalle Kurppa (Contributor), Pekka Collin (Contributor), Heini Huhtala (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  9 May 2011

  Activity: Talk or presentation › Conference presentation

• Toimiminen vastaväittäjänä

  Katri Lindfors (Pre-examiner or opponent of dissertation)

  15 Mar 2011

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Passive transfer of celiac disease into mice – Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  19 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 inhibit vasculature in vitro and in vivo through Rho B

  Suvi Kalliokoski (Contributor), Stefania Martucciello (Contributor), Miha Lavric (Contributor), Cristina Nadalutti (Contributor), Rafael Frias (Contributor), Ana-Marija Sulic (Contributor), Carla Esposito (Contributor), Lauri Pelliniemi (Contributor), Anne Roivainen (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Sergio Caja (Contributor)

  19 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  19 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Epithelial barrier integrity and autoantibodies in celiac disease - focus on pathogenesis and novel treatment options

  Katri Lindfors (Position of trust)

  2011 → 2016

  Activity: Other › Leadership of a scientific program or project

• Opinnäytetöiden ohjaus, Väitöskirja: Characterizing and modifying the intestinal barrier in coeliac disease

  Katri Lindfors (Examiner)

  2011 → 2014

  Activity: Evaluation, examination and supervision › Supervisor of doctoral candidate

• BMC Immunology (Journal)

  Katri Lindfors (Reviewer)

  2011

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Kidney Research UK (External organisation)

  Katri Lindfors (Reviewer)

  2011

  Activity: Membership › Position of trust in a funding organization

• Journal of Biological Chemistry (Journal)

  Katri Lindfors (Reviewer)

  2011

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Scandinavian Journal of Gastroenterology (Journal)

  Katri Lindfors (Reviewer)

  2011

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Molecular Nutrition and Food Research (Journal)

  Katri Lindfors (Reviewer)

  2011

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Opinnäytetöiden ohjaus, Pro gradu -tutkielma: Tumorigenesis in celiac disease

  Katri Lindfors (Examiner)

  2011 → …

  Activity: Evaluation, examination and supervision › Supervisor of master student

• PloS One (Journal)

  Katri Lindfors (Reviewer)

  2011

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  L Airaksinen (Contributor), K Kaukinen (Contributor), J Schleutker (Contributor), P Saavalainen (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  15 Dec 2010

  Activity: Talk or presentation › Conference presentation

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease? – a proof-of-concept study

  T Rauhavirta (Speaker), R Kivistö (Speaker), K Kaukinen (Speaker), I Korponay-Szabo (Speaker), PT Männistö (Speaker), JA Garcia-Horsman (Speaker), A Mongeot (Speaker), R Collighan (Speaker), M Griffin (Speaker), M Mäki (Speaker) & K Lindfors (Speaker)

  15 Dec 2010

  Activity: Talk or presentation › Conference presentation

• Passive transfer of celiac disease into mice - Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 Dec 2010

  Activity: Talk or presentation › Conference presentation

• Toimiminen vastaväittäjänä

  Katri Lindfors (Pre-examiner or opponent of dissertation)

  22 Oct 2010

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  L Airaksinen (Contributor), K Kaukinen (Contributor), J Schleutker (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  10 Sept 2010

  Activity: Talk or presentation › Conference presentation

• Epithelial transport and deamidation of gliadin peptides - a role for coeliac disease patient IgA

  T Rauhavirta (Contributor), S-W Qiao (Contributor), Z Jiang (Contributor), E Myrsky (Contributor), J Loponen (Contributor), IR Korponay-Szabó (Contributor), H Salovaara (Contributor), JA Garcia-Horsman (Contributor), J Venäläinen (Contributor), PT Männistö (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor), K Kaukinen (Contributor) & K Lindfors (Contributor)

  10 Sept 2010

  Activity: Talk or presentation › Conference presentation

• Celiac patient autoantibodies against transglutaminase 2 disturb angiogenesis in vitro and in vivo

  Sergio Caja (Contributor), Cristina Nadalutti (Contributor), Suvi Kalliokoski (Contributor), Essi Myrsky (Contributor), Anne Roivainen (Contributor), Lauri Pelliniemi (Contributor), Rafael Frias (Contributor), Anamaria Sulic (Contributor), Miha Lavric (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Mongeot Alexandre (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  19 Jul 2010

  Activity: Talk or presentation › Conference presentation

• Gliadin induced apoptosis in T84 three dimensional cell model

  A. Castellanos-Rubi (Contributor), JR. Bilbao (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  11 Jun 2010

  Activity: Talk or presentation › Conference presentation

• Identification of the disease-specific coeliac epitope of transglutaminase 2 and possible antibody-based therapy

  Katri Lindfors (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  10 Jun 2010

  Activity: Talk or presentation › Conference presentation

• Detoxification of gluten by germinating cereal enzymes: Implications for new treatment of coeliac disease

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor) & Markku Mäki (Contributor)

  8 Jun 2010

  Activity: Talk or presentation › Conference presentation

• Presentation

  Katri Lindfors (Speaker)

  9 Apr 2010

  Activity: Talk or presentation › Public talk

• Features of celiac disease can be induced in mice by passive transfer of patient serum

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific IgA enhances the transepithelial passage of gliadin peptides without breaking the epithelial barrier

  T Rauhavirta (Contributor), K Kaukinen (Contributor), S-W Qiao (Contributor), IR Korponay-Szabo (Contributor), LM Sollid (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo

  S Caja (Speaker), S Martucciello (Speaker), M Lavric (Speaker), D Sblattero (Speaker), R Marzari (Speaker), M Mäki (Speaker), K Kaukinen (Speaker) & K Lindfors (Speaker)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Downregulation of tissue transglutaminase and its implications for coeliac disease

  C Nadalutti (Speaker), K Viiri (Speaker), K Kaukinen (Speaker), M Mäki (Speaker) & K Lindfors (Speaker)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Digestive and liver diseases (Journal)

  Katri Lindfors (Reviewer)

  2010

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Journal of Proteome Research (Journal)

  Katri Lindfors (Reviewer)

  2010

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Expert Opinion on Therapeutic Targets (Journal)

  Katri Lindfors (Reviewer)

  2010

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Molecular Nutrition and Food Research (Journal)

  Katri Lindfors (Reviewer)

  2010

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Allergologia et Immunopathologia (Journal)

  Katri Lindfors (Reviewer)

  2010

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Features of celiac diasease can be induced in mice by passive transfer of patient serum

  S Kalliokoski (Speaker), S Caja (Speaker), Ilma Korponay-Szabó (Speaker), O Koskinen (Speaker), M Mäki (Speaker), K Kaukinen (Speaker) & K Lindfors (Speaker)

  18 Dec 2009

  Activity: Talk or presentation › Conference presentation

• Downregulation of transglutaminase and its implications for coeliac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  16 Dec 2009

  Activity: Talk or presentation › Conference presentation